Elazar Rabbani, CEO and Secretary at ENZO BIOCHEM INC (ENZ), bought 20,000 shares at $2.29 ($46K) on 2011-11-16, disclosed to the SEC on 2011-11-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.28 | 6,600 | $15K | 32.9% |
| 2 | $2.28 | 600 | $1K | 3.0% |
| 3 | $2.29 | 3,600 | $8K | 18.0% |
| 4 | $2.29 | 5,700 | $13K | 28.5% |
| 5 | $2.30 | 2,800 | $6K | 14.1% |
| 6 | $2.30 | 600 |
| $1K |
| 3.0% |
| 7 | $2.30 | 100 | $230 | 0.5% |
| Total | $2.29 avg | 20,000 | $46K | 100% |
| Filing → |
| ENZ | SELL | 2017-10-27 | $1.5M | — | Filing → |